Abstract
We aimed to compare Perfusion Imaging Mismatch (PIM) and Clinical Core Mismatch (CCM) criteria in ischemic stroke patients to identify the effect of these criteria on selected patient population characteristics and clinical outcomes. Patients from the INternational Stroke Perfusion Imaging REgistry (INSPIRE) who received reperfusion therapy, had pre-treatment multimodal CT, 24-h imaging, and 3 month outcomes were analyzed. Patients were divided into 3 cohorts: endovascular thrombectomy (EVT), intravenous thrombolysis alone with large vessel occlusion (IVT-LVO), and intravenous thrombolysis alone without LVO (IVT-nonLVO). Patients were classified using 6 separate mismatch criteria: PIM-using 3 different measures to define the perfusion deficit (Delay Time, Tmax, or Mean Transit Time); or CCM-mismatch between age-adjusted National Institutes of Health Stroke Scale and CT Perfusion core, defined as relative cerebral blood flow <30% within the perfusion deficit defined in three ways (as above). We assessed the eligibility rate for each mismatch criterion and its ability to identify patients likely to respond to treatment. There were 994 patients eligible for this study. PIM with delay time (PIM-DT) had the highest inclusion rate for both EVT (82.7%) and IVT-LVO (79.5%) cohorts. In PIM positive patients who received EVT, recanalization was strongly associated with achieving an excellent outcome at 90-days (e.g., PIM-DT: mRS 0-1, adjusted OR 4.27, P = 0.005), whereas there was no such association between reperfusion and an excellent outcome with any of the CCM criteria (all p > 0.05). Notably, in IVT-LVO cohort, 58.2% of the PIM-DT positive patients achieved an excellent outcome compared with 31.0% in non-mismatch patients following successful recanalization (P = 0.006).Conclusion: PIM-DT was the optimal mismatch criterion in large vessel occlusion patients, combining a high eligibility rate with better clinical response to reperfusion. No mismatch criterion was useful to identify patients who are most likely response to reperfusion in non-large vessel occlusion patients.
Highlights
Selection of patients using target mismatch can identify acute ischemic stroke patients who are most likely to benefit from intravenous thrombolysis (IVT) or endovascular thrombectomy (EVT) in an extended time window [1,2,3]
The DAWN trial [1] applied a Clinical-Core Mismatch (CCM) where an age-adjusted National Institutes of Health Stroke Scale (NIHSS) score was used as a surrogate for the total perfusion deficit, in combination with a small age-adjusted ischemic core define mismatch
From the INternational Stroke Perfusion Imaging REgistry (INSPIRE) database, patients with anterior circulation ischemic stroke were included in this study if they fulfilled the following criteria: (i) Received reperfusion therapy: Endovascular Thrombectomy (EVT) or Intravenous Thrombolysis (IVT) based on institutional guidelines
Summary
Selection of patients using target mismatch can identify acute ischemic stroke patients who are most likely to benefit from intravenous thrombolysis (IVT) or endovascular thrombectomy (EVT) in an extended time window [1,2,3]. The most common set of thresholds defining penumbra and core are time to peak of the residual function (Tmax) > 6 s and relative cerebral blood flow (rCBF) 3 s and rCBF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.